| FSMAX | PMEGX | FSMAX / PMEGX | |
| Total Expense Ratio | 0.04 | 0.61 | 6% |
| Annual Report Gross Expense Ratio | 0.04 | 0.61 | 6% |
| Fund Existence | 15 years | 30 years | - |
| Gain YTD | 13.370 | 0.328 | 4,076% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 40.1B | 2.25B | 1,783% |
| Annual Yield % from dividends | 0.49 | 0.11 | 468% |
| Returns for 1 year | 13.05 | -17.61 | -74% |
| Returns for 3 years | 63.92 | -16.49 | -388% |
| Returns for 5 years | 32.77 | -37.15 | -88% |
| Returns for 10 years | 133.42 | 16.21 | 823% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NULG | 111.10 | 0.56 | +0.51% |
| Nuveen ESG Large-Cap Growth ETF | |||
| RAAA | 25.06 | 0.03 | +0.14% |
| Reckoner Yield Enhanced AAA CLO ETF | |||
| PUSH | 50.18 | 0.02 | +0.04% |
| PGIM Ultra Short Municipal Bond ETF | |||
| SPTB | 29.20 | -0.03 | -0.12% |
| State Street® SPDR® Portfolio Trs ETF | |||
| BIS | 11.96 | -0.03 | -0.25% |
| ProShares UltraShort Nasdaq Biotech | |||